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Introduction
Friedreich’s ataxia, the most common hereditary
ataxia, is a progressive neurodegenerative disease
caused by a large expansion of the trinucleotide repeat
GAA within the ﬁrst intron of the X25 gene on human
chromosome 9q13 [1]. The expanded repeat causes
severe reduction in the amount of the corresponding
mRNA and consequently in the amount of frataxin
[2,3], a highly conserved nuclear-encoded mitochon-
drial protein that has been implicated in iron metabo-
lism [4–7]. However, the function of frataxin is still not
clearly established. Frataxin has been suggested to act
as an iron chaperone [8] or as a scavenger that is able
to sequester mitochondrial iron through formation of
high-molecular-weight aggregates and to maintain it in
a bioavailable form [9]. More recently, we have shown
that CyaY, the frataxin bacterial orthologue, is an
inhibitor of the iron–sulfur cluster enzymatic machin-
ery, and proposed that this function is shared by all
members of the family [10]. To validate these hypothe-
ses, it is important to identify the functionally essential
regions of the protein and show that they are con-
served throughout the frataxin family. Regions that
are not conserved may explain species-speciﬁc special-
ized functions.
Two distinct regions can be identiﬁed in the frataxin
sequence: an N-terminus that is absent in bacteria, and
a C-terminal domain that is present in all species from
bacteria to human, which folds into a globular
domain. The structure of the evolutionarily conserved
domain of various species has been described [11–15].
However, little remains known about the eukaryotic
N-terminus, which has been suggested to perform a
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Frataxin is a highly conserved nuclear-encoded mitochondrial protein
whose deﬁciency is the primary cause of Friedreich’s ataxia, an autosomal
recessive neurodegenerative disease. The frataxin structure comprises a
well-characterized globular domain that is present in all species and is pre-
ceded in eukaryotes by a non-conserved N-terminal tail that contains the
mitochondrial import signal. Little is known about the structure and
dynamic properties of the N-terminal tail. Here, we show that this region
is ﬂexible and intrinsically unfolded in human frataxin. It does not alter
the iron-binding or self-aggregation properties of the globular domain.
It is therefore very unlikely that this region could be important for the
conserved functions of the protein.
Abbreviation
hfra, human frataxin.
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structural gating role that would inhibit the iron-pro-
moted binding of frataxin to IscU, a scaffold protein
involved in the iron–sulfur cluster assembly [16].
In this paper, we report on a study of the structural
and dynamic properties of the N-terminus of human
frataxin (hfra). We have studied both the mature form,
which spans residues 81-210 of the precursor protein
[17,18], and a longer construct comprising residues
61-210. Longer forms of the protein are interesting as
mitochondrial maturation occurs via a two-step mech-
anism that ﬁrst generates a 19 kDa intermediate
comprising residues 42-210, which further matures to
the ﬁnal species [17,18]. Other truncated forms, such as
56-210 and 78-210, are also present in vivo when the
normal maturation process of frataxin is impaired [18].
Based on several independent parameters, we show
that the N-terminal extension behaves in solution as a
ﬂexible and intrinsically unfolded tail that does not
inﬂuence the properties of the nearby domain.
Results
The N-terminus of eukaryotic frataxins is
non-conserved
We ﬁrst analysed the degree of conservation of fratax-
ins among eukaryotes. We BLAST-retrieved and
aligned sequences from yeast or unicellular algae to
those of Homo sapiens (Fig. 1A) [19,20]. The alignment
is straightforward as the sequences share 30–50% iden-
tity and up to 80% similarity, with almost no inser-
tions ⁄deletions in the evolutionarily conserved domain.
Sequence conservation decreases at the N-terminus,
which contains the mitochondrial import signal. The
secondary structure predictions correctly identify the
structural elements in the domain, and suggest the
presence of potentially structured regions in the N-ter-
minus but with low conﬁdence (i.e. below 50%).
Interestingly, large portions of the N-terminal exten-
sion were predicted to be intrinsically unfolded by the
widely used DISEMBL and PONDR web servers
(http://dis.embl.de/ and http://www.pondr.com/) [21,22]
(Fig. 1B). The programs also predict two regions in the
evolutionary conserved domain to be intrinsically
unfolded. The ﬁrst is around residues 145–165 and con-
tains the well-structured and rigid b-strands b3–b5. This
is presumably because this region contains two poten-
tially low-complexity sequences (two hydrophobic
stretches interleaved by an SSPSSG sequence rich
in small amino acids). The second comprises the
C-terminus, which does not adopt a regular conforma-
tion, but is rather rigid as it is sandwiched between the
two helices.
The N-terminal tail of hfra does not alter the
structure of the globular domain
We studied experimentally the behaviour of three con-
structs. One [hfra(81-210)] corresponds to the mature
form [17,18]. The second spans residues 61-210
[hfra(61-210)]. As described previously [11], unless
otherwise protected, this construct degrades spontane-
ously to produce a fragment comprising residues
75-210 [hfra(75-210)]. However, we found that use of
the Complete anti-protease cocktail (Roche) prevents
proteolytic cleavage. This enabled us to develop a
method for comparing the behaviour of the three con-
structs that provides information about the structure
of both the mature and the precursor forms.
The HSQC spectrum of hfra(81-210) is largely
superimposable with that of a shorter construct,
hfra(91-210), described in a previous study [11], that
spans the sequence of the evolutionary conserved
domain (Fig. 2A). Only minor local differences (i.e.
less than 0.14 and 0.6 ppm in the proton and nitrogen
dimensions, respectively) were observed (Fig. 2B). The
differences cluster in the regions spatially close to
Asp91, indicating the absence of speciﬁc interactions
between the N-terminal extension and the domain.
Therefore, the N-terminal tail has no inﬂuence on the
structure of the conserved domain. The spectrum of
hfra(81-210) contains seven clearly identiﬁable addi-
tional peaks that are absent in hfra(91-210) and were
unambiguously assigned to residues 82-90 (the reso-
nance of residue 83 is missing, residue 87 is a Pro). On
average, they are less intense than the other reso-
nances. Some also have a clear pH dependence and are
absent above pH 7. This suggests that the correspond-
ing residues are exposed to the solvent and are ﬂexible,
as is typical for unstructured regions.
The spectra of the longer constructs are superposable
with that of hfra(81-210) with no evidence of additional
peaks, strongly suggesting that further elongation does
not contribute to structuring the N-terminus (data not
shown). If visible at all, the resonances of the additional
residues must either be hidden in the crowded regions of
the spectrum, which is typical of random coil conforma-
tions, or in intermediate exchange with the solvent, as
expected for a ﬂexible and unstructured chain.
The N-terminal tail is intrinsically unfolded
Analysis of the chemical shifts with various predictive
tools to estimate the degree of structure of the N-ter-
minal extension provided further evidence that the
N-terminal tail is intrinsically unfolded. Analysis of
the secondary chemical shifts using chemical shift
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indices [23] supports the hypothesis of am absence of
secondary structure in the region 81-92 (Fig. 3A). As a
control, this method correctly predicted the positions
of the secondary structure elements in the domain.
Finally, we used random coil index analysis to esti-
mate the ﬂexibility of the N-terminal extension in
terms of the root mean square ﬂuctuations of structure
ensemble from the experimental chemical shifts
(Fig. 3B) and order parameters (Fig. 3C) [24]. This
analysis provides a semi-quantitative means to com-
bine the chemical shift values from six nuclei (13Ca,
13Cb, 13CO, 15N, HN and Ha) into a single parameter
that correlates with the amplitudes of backbone
protein motions. Both plots strongly support high
ﬂexibility of the N-terminus.
Relaxation experiments show that the
N-terminus is flexible
A more direct analysis of the dynamics was achieved
by measuring the NMR relaxation parameters (Fig. 4).
The experimental T1 values range from 518.1 to
941.0 ms. The maximal value was observed for the
C-terminal residue Ala210. If this residue is omitted,
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Fig. 1. Sequence analysis. (A) Alignment of eukaryotic frataxins, colour-coded to highlight sequence conservation. An arrow indicates the
start of the evolutionarily conserved globular domain. Asterisks, colons and dots indicate identical, conserved, and semi-conserved residues,
respectively. The alignment was prepared using CLUSTAL X software [20]. (B) Predictions of intrinsically unfolded regions along the sequence
of the hfra precursor (residues 1-210). Left panel: DISEMBL prediction [21]. The green curve is the prediction for missing coordinates, the
red curve indicates the hot loop network, and the blue curve indicates coil according to the DISEMBL definition [21]. Horizontal lines corre-
spond to the random expectation level for each predictor. For coils and hot loops, the prior probabilities were used, and a neural network
score of 0.5 was used for REMARK465. Right panel: PONDR prediction [22]. The predicted disordered regions are those with higher positive
values.
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the mean T1 is 635.8 ms. The T2 values range from
86.1 to 402.0 ms, with Ala210 again having the largest
value. The mean T2 value, excluding this residue, is
111.4 ms. Negative NOE values were observed for the
N-terminal residues and for the ﬁrst Gly in the GHPG
motif, which has an unusual chemical shift in the pro-
ton dimension [25]. Its negative NOE value can almost
certainly be explained by its proximity to the water sig-
nal, and therefore by the effect of water suppression.
The N-terminal tail does not alter the
iron-binding properties of hfra
To check whether the unstructured tail inﬂuences the
iron-binding properties of hfra, we titrated hfra(81-210)
both by Fe2+ and Fe3+ using NMR as the detection
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Fig. 2. Comparison of the NMR chemical shifts of hfra(81-210) and
the evolutionarily conserved globular domain hfra(91-210). (A)
Superposition of the 15N HSQC spectra of hfra(81-210) (in black)
and hfra(91-210) (in red). (B) Plots of the chemical shift differences
between the two constructs in the nitrogen dimension (lower
panel) and proton dimension (upper panel) as a function of the
sequence.
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Fig. 3. Assessment of the dynamic properties of hfra(81-210) as
calculated from the chemical shift values. (A) From top to bottom:
chemical shift indices of Ha, Ca and Cb, calculated as described
previously [23]. (B) Random coil index and (C) order parameters
[24].
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tool. As previously observed [26], anaerobic Fe2+ titra-
tion led to disappearance of the amide resonances of res-
idues 112, 113, 115, 125 and 126, and shift and ⁄or
broadening of residues 104, 109, 111, 114, 122 and 124
at a 1:2 protein:iron molar ratio (Fig. 5A). When
hfra(81-210) was titrated with Fe3+, we observed visible
precipitation, suggesting that, at neutral pH, precipita-
tion of the ferric hydroxide competes with binding and
predominates at these concentrations (data not shown).
This is in agreement with the weak binding constant
found previously [8]. We obtained similar results with
the longer constructs (data not shown).
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Fig. 4. NMR relaxation parameters. From top to bottom, the three
panels represent the NOE, T1, and T2 values, respectively, as
measured at 600 MHz and 25 C.
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Fig. 5. Probing the iron-binding and aggregation properties of
hfra(81-210). (A) Histogram of the chemical shift perturbation
observed when titrating hfra(81-210) with two molar equivalents of
Fe2+. Filled circles correspond to residues whose resonances disap-
pear, open circles are used to indicate positions (including prolines)
for which the HSQC resonance is missing. (B) Gel filtration elution
profile of hfra(60-210) (black line), hfra(81-210) (light grey) and
hfra(91-210) (dark grey) using a preparative Superdex 75 16 ⁄ 60 col-
umn (GE Healthcare). (C) Gel filtration elution profile of hfra(81-210)
in the presence (black line) and absence (grey line) of Fe2+ using a
pre-packed analytical HiLoad 10 ⁄ 30 Superdex 75 column (GE
Healthcare).
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The N-terminal tail does not alter the
monodispersity of hfra
We then compared the aggregation properties of our
constructs. We noticed that, during puriﬁcation by gel
ﬁltration on a Superdex 75 column, hfra(61-210) runs
as two distinct species. One corresponds to the mono-
mer, while the second is present in the excluded vol-
ume of the column and corresponds to a large hfra
aggregate, as supported by SDS–PAGE analysis
(Fig. 5B). No such behaviour was observed with
hfra(81-210), suggesting that the additional residues
could be responsible for previous results showing that
hfra can aggregate under speciﬁc conditions [27].
To investigate the ability of the extended proteins to
aggregate in the presence of Fe2+, we studied the chro-
matographic proﬁle of hfra(81-210) in the presence of
a 20-fold excess of Fe(NH4)2(SO4)2 (Fig. 5C, dark
line). For comparison, the elution proﬁle of the apo-
protein is shown (Fig. 5C, grey line). In both cases, we
detected the peak corresponding to the monomeric
form but no high-molecular-weight aggregates,
although they were observed in similar experiments for
the bacterial and yeast orthologues CyaY and Yfh1
[28,29]. These results conﬁrm that hfra is not prone to
iron-induced aggregation, as also observed for the
isolated globular domain [28].
Discussion
We have addressed here the question of whether the
N-terminal tail that is present only in eukaryotic
frataxins is structured, taking the human protein as a
model. While ﬂexibility of this region was suggested
by the absence of a detectable density map for resi-
dues 84-89 in the crystal structure of the hfra(84-210)
construct [13] and by the absence of stabilizing ⁄desta-
bilizing effects of N-terminal extensions on the ther-
modynamic stability of the evolutionary conserved
domain [11], no direct information was available for
what we now know to be the mature hfra [17,18].
The equivalent region of the yeast orthologue appears
to adopt a relatively well-deﬁned conformation in
both the NMR [14] and X-ray structures [15]. Here
we provide complementary evidence showing that the
N-terminal tail of hfra is unstructured and ﬂexible,
thus indicating that the region is intrinsically
unfolded.
The concept of intrinsically unfolded proteins, as
opposed to the widespread traditional view that pro-
teins must have a ﬁxed tertiary structure, has recently
attracted much interest [30]. This has led to the realiza-
tion that a large number of soluble proteins are either
completely unstructured or contain unstructured
regions. The ﬂexibility of these tracts is often necessary
for their functions through an induced ﬁt mechanism
that occurs only upon molecular interactions.
What could then be the role of the non-conserved
N-terminal tail in the function of human frataxin?
While some conservation is observed among mam-
mals, the sequence is rather divergent when consider-
ing the whole eukaryotic family. This indicates that,
if it takes part of any process at all, the extension
could contribute to speciﬁc species adaptations. The
corresponding N-terminal tail of yeast frataxin, which
contains a 310 helix, was suggested to stabilize a
trimer [31]. This oligomer was thought to be the
functional unit for iron transferring to its partners
and the building block for frataxin oligomerization
[32]. At variance with these results, we have previ-
ously shown that the N-terminal tail does not con-
tribute to protein stability [11]. In this work, we
provide direct evidence that the tail (in all degrees of
elongation studied here) does not alter the structure,
the iron-binding properties or the monodispersity of
the evolutionarily conserved domain even in the
presence of high concentrations of iron.
We propose that the role of the N-terminal tail in
mature hfra, which is shorter than previously suggested
[17,18,33], is either to take part in and stabilize the
interactions with other protein partners (e.g. the Nfs1
desulfurase or ferrochelatase), or, more simply, to act
as a spacer that is necessary to allow correct process-
ing of the protein by the MPP protease. It is reason-
able to assume that, if the cleavage site were too
close to the compact and rather rigid evolutionarily
conserved domain, interaction with MPP could be
difﬁcult and cleavage less efﬁcient. The latter hypo-
thesis may explain the poor conservation of this
region. More studies are required to test this working
hypothesis.
Experimental procedures
Bioinformatics tools
Eukaryotic frataxin sequences were retrieved by a BLASTp
search (http://blast.ncbi.nlm.nih.gov) [19] and aligned using
Clustal X version 2.0 (http://www.clustal.org) [20]. Intrinsi-
cally unfolded regions were predicted using the DISEMBL
(http://dis.embl.de/) [21] and PONDR (http://www.pondr.
com/) [22] web servers. Chemical shift analysis was carried
out using the CSI (chemical shift indices) (http://www.
bionmr.ualberta.ca/bds/software/csi/latest/csi.html) [23] and
RCI (random coil index) (http://wishart.biology.ualberta.
ca/rci/cgi-bin/rci_cgi_1_e.py) [24] web servers.
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Protein production
The constructs used span the sequence of hfra (residues 61-
210 and 81-210 of Genbank accession number U43752).
The proteins were produced as His-tagged fusion constructs
cloned into a pET9-derived plasmid vector as previously
described [11]. In brief, the constructs were expressed in
Escherichia coli strain BL21 (DE3), transformed with modi-
ﬁed pET vector DNA, and puriﬁed. The cells were inocu-
lated into Luria broth (LB) medium with kanamycin
(30 mgÆL)1) and induced using isopropyl thio-b-d-thiogalac-
toside (IPTG). Ni-NTA chromatography was used as the
ﬁrst step of puriﬁcation, using imidazole for elution. Final
puriﬁcation was achieved by gel ﬁltration chromatography
on a Superdex 75 16 ⁄ 60 column (GE Healthcare, Chalfont
St Giles, UK). The purity of the recombinant proteins was
checked by SDS–PAGE after each step of puriﬁcation and
by mass spectrometry on the ﬁnal products. Complete anti-
protease cocktail (Roche, Basel, Switzerland) was used to
prevent proteolytic cleavage of hfra(61-210).
15N- and 15N,13C-labelled samples were produced by
growing the bacteria in minimal medium using (15NH4)2SO4
and 13C6-d-glucose as sole sources of nitrogen and carbon,
respectively.
NMR measurements
The experiments were performed at 25 C on a Varian (Palo
Alto, CA, USA) Inova 600 MHz NMR spectrometer
equipped with a triple-resonance gradient probe. Protein
samples (0.3–1 mm) were prepared in either 10 mm sodium
phosphate buffer at pH 7.0 or 8.0 or 50 mm Tris ⁄HCl, 10 mm
NaCl at pH 7.2 with 10% D2O. Assignment of the region
91-210 was retrieved from the BMRB database (entry number
4342). Assignment of the resonances of residues in the N-
terminal extension was obtained by standard methods using
HNCA, HNCOCA and 15N NOESY-HSQC experiments.
Thirteen data points were collected for T1 and T2 mea-
surements, using delays of 1.5, 49.6, 97.8, 145.9, 194.1,
250.3, 298.4, 394.8, 499.0, 747.9, 996.7, 1245.5 and
1494.3 ms and 0, 8.7, 17.4, 26.1, 34.7, 43.4, 52.1, 60.8, 69.5,
86.9, 104.2, 121.6 and 147.7 ms, respectively. T1 and T2
spectra were recorded as 256 · 1024 (440 · 2048) complex
data points with 16 scans. Spectral widths were 1800 and
6500 Hz along 15N and 1H dimensions, respectively. Het-
eronuclear NOE spectra were recorded as 128 · 1024 com-
plex data points with 48 scans. The spectral widths for 15N
and 1H were as given above. NOE values were determined
as the ratio of peak intensity in the absence and the pres-
ence of proton saturation.
Ferrous and ferric ammonium sulfate salts (Sigma, St
Louis, MO, USA) were used for iron titrations, which were
performed under anaerobic conditions for Fe2+, using a
Belle chamber (Belle Technology, Weymouth, UK) under
nitrogen atmosphere, and under aerobic conditions for Fe3+.
All spectra were processed by nmrpipe. Intensities were
extracted using non-linear spectral lineshape modelling, and
ﬁt to single exponentials using routines within NMRPipe
[34].
Aggregation studies
A pre-packed HiLoad 10 ⁄ 30 Superdex 75 column (GE
Healthcare) was equilibrated with Hepes buffer (pH 7.4)
and 150 mm NaCl. Samples (1 mL) were loaded using a
static loop (1 mL), and were eluted with the same equili-
brating buffer. Samples were prepared by incubating 20 lm
protein in a 20-fold excess of Fe(NH4)2(SO4)2 for 1 h at
30 C. After centrifugation at 13 000 g for 5 min, the
supernatant was loaded on the column.
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